Skip to main content

Advertisement

Table 3 Cardiovascular risk parameters

From: Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain

Cardiovascular risk components Values in the sample mean ± SD [95% CI] Reference values Percentage values of the sample within reference
BMI 34.8 ± 5.8 [32.9-36.7] 18.5-24.91 0% (n = 0)
Weight (kg) 85.5 ± 14.9 [80.6-90.4]   
Waist circumference (cm) 106.7 ± 12.2 [102.7-110.7] < 88 females/102 males2 5.3% (n = 2) females/13.2% (n = 5) males
SBP (mmHg) 133.6 ± 13.8 [128.4-138.9] < 1401 47.4% (n = 18)
DBP (mmHg) 79.3 ± 5.9 [7781.–6] < 901 68.4% (n = 26)
Glucose (mg/dl) 141.3 ± 40.7 [127.5-155] < 1003 11.1% (n = 4)
Total cholesterol (mg/dl) 171.9 ± 23.4 [164180]– < 2001 91.7% (n = 33)
HDL-c (mg/dl) 56.8 ± 11 [5360.–5] > 501 66.7% (n = 24)
LDL-c (mg/dl) 92.1 ± 20.7 [85.2-99.1] < 1301 89.5% (n = 34)
Triglycerides (mg/dl) 123.1 ± 76.7 [97.2-149] < 2001 91.7% (n = 33)
HbA1c (%) 6.8 ± 1.3 [6.3-7.2] < 7%3 44.7% (n = 17)
Fibrinogen (mg/dl) 339.3 ± 85.8 [309.8-368.8] 200-4004 77.1% (n = 27)
us-CRP (mg/L) 6.3 ± 7.4 [3.8-8.8] < 31 44.7% (n = 17)
  1. 1SEEDO 2007, 2ATP III 2002, 3ADA 2012, 4Gailani D, Neff AT 2008.
  2. ADA = American Diabetes Association; ATPIII: adult treatment panel III; BMI = body mass index; HbA1c = glycosylated hemoglobin; HDL-c = high-density lipoprotein cholesterol; LDL-c = low-density lipoprotein cholesterol; SEEDO = Spanish Society for the Study of Diabetes and Obesity; us-CRP = ultrasensitive C reactive protein.